Review



erfin  (Novartis)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Novartis erfin
    Key characteristics of the six “drugs of interest” (DOIs) used for the development of the benchmark reference dataset
    Erfin, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erfin/product/Novartis
    Average 90 stars, based on 1 article reviews
    erfin - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR"

    Article Title: Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR

    Journal: Drug Safety

    doi: 10.1007/s40264-020-00912-9

    Key characteristics of the six “drugs of interest” (DOIs) used for the development of the benchmark reference dataset
    Figure Legend Snippet: Key characteristics of the six “drugs of interest” (DOIs) used for the development of the benchmark reference dataset

    Techniques Used:



    Similar Products

    erfin  (Novartis)
    90
    Novartis erfin
    Key characteristics of the six “drugs of interest” (DOIs) used for the development of the benchmark reference dataset
    Erfin, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erfin/product/Novartis
    Average 90 stars, based on 1 article reviews
    erfin - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Key characteristics of the six “drugs of interest” (DOIs) used for the development of the benchmark reference dataset

    Journal: Drug Safety

    Article Title: Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR

    doi: 10.1007/s40264-020-00912-9

    Figure Lengend Snippet: Key characteristics of the six “drugs of interest” (DOIs) used for the development of the benchmark reference dataset

    Article Snippet: Terbinafine , Novartis , Lamisil (fungal infections such as Tinea corporis, Tinea cruris and Tinea pedis, onychomycosis) , 418 (47.5) , Nafin, Erfin, Terbin, Lamisil, Silka, Terbit, Viras, Binter, Tacna, Finex , 32,867 (40.9) , 24,781 (42.8) , 37 (3.5).

    Techniques: